|   | ![]() Your Search for acyclovir or zovirax matched 1000 Documents (Page 1 of 34). You may want to refine your search. Results Indexed by relevance. |
| 1. |
UNITED STATES: Herpes Drug May Help Control AIDS Virus (100%) Abstract: A cheap, generic treatment used against herpes can also lower HIV viral load, researchers reported Wednesday. However, acyclovir works against HIV only in tissues that are also infected with herpes. The findings could help explain why some studies have shown that patients taking acyclovir have a lower HIV viral load, w ... http://www.aegis.org/news/ads/2008/ad081742.html File Name: ad081742.html, Size: 10KB, Last Modified: Thursday, September 11, 2008 at 3:00:00 PM |
| 2. |
abs03048.txt (100%) Abstract: TY - ABST PB - XVII International AIDS Conference. 3-8 August 2008, Mexico City, Mexico SN - 978-92-95069-05-3 U1 - WEPE0248 T1 - Strengthening HIV prevention by adding acyclovir roll-out strategy through the STI (sexually transmitted infection) control programme in Botswana p>b>ISSUES<b> HIV preval ... http://www.aegis.org/conferences/iac/2008/abs03048.txt File Name: abs03048.txt, Size: 2KB, Last Modified: Wednesday, August 13, 2008 at 8:12:04 PM |
| 3. |
AEGiS-CATIE: TraitementSida 85: Acyclovir -- aucun avantage sur le plan de la survie dans une étude d'envergure - 1998 mars (100%) Abstract: Les personnes infectées par le VIH peuvent aussi être infectées par d'autres microbes tels que ceux qui sont responsables de l'herpès. Quand ces coinfections font rage, elles peuvent accroître la production de VIH, et peut-être ainsi accélérer le déclin du système immunitaire. ... http://www.aegis.org/pubs/catie/1998/catf8504.html File Name: catf8504.html, Size: 12KB, Last Modified: Tuesday, March 06, 2007 at 6:43:37 PM |
| 4. |
AEGiS-CATIE: Acyclovir: no survival benefit seen in a large study - March 1998 (100%) Abstract: People infected with HIV may also be co-infected with other microbes such as those that cause herpes. When these co-infections flare, they can increase production of HIV, perhaps leading to faster destruction of the immune system. So some doctors think that regular use of anti-herpes drugs may keep these viruses from b ... http://www.aegis.org/pubs/catie/1998/cate8504.html File Name: cate8504.html, Size: 10KB, Last Modified: Tuesday, March 06, 2007 at 6:43:30 PM |
| 5. |
AEGiS-CATIE: INFECTION FIGHTERS: When herpes drugs fail -- interferon? (100%) Abstract: Background ... http://www.aegis.org/pubs/catie/1996/cate7406.html File Name: cate7406.html, Size: 6KB, Last Modified: Monday, July 12, 2004 at 4:00:12 PM |
| 6. |
Value of long-term administration of acyclovir and similar agents for protecting against AIDS-related lymphoma: case-control and historical cohort studies [see comments] (100%) Abstract: Acyclovir or similar agents with activity against Epstein-Barr virus (EBV) theoretically may prevent non-Hodgkin s lymphoma (NHL) in AIDS. A case-control study of 29 patients with AIDS-related NHL and 58 matched control subjects assessed the ... http://www.aegis.org/aidsline/2000/oct/a00a0345.html File Name: a00a0345.html, Size: 10KB, Last Modified: Saturday, October 28, 2000 at 8:12:04 PM |
| 7. |
Herpes simplex replication and dissemination is not increased by corticosteroid treatment in a rat model of focal Herpes encephalitis. (100%) Abstract: Neurological damage in Herpes simplex type 1 encephalitis results from neuronal cell death secondary to viral invasion, and from inflammatory changes and cerebral oedema secondary to the immune response to the virus. Corticosteroids could have an important role in the management of Herpes simplex encephalitis because ... http://www.aegis.org/aidsline/2000/aug/a0080674.html File Name: a0080674.html, Size: 11KB, Last Modified: Monday, August 28, 2000 at 8:12:04 PM |
| 8. |
Acyclovir-resistant herpes zoster in 18 HIV-infected patients: Results of treatment with foscarnet. (100%) Abstract: OBJECTIVE: To report the epidemiological and clinical features of acyclovir-resistant herpes zoster and to evaluate the efficacy of foscarnet. DESIGN AND METHODS: Retrospective study of all consecutive cases of acyclovir-resistant herpes zoster. Herpes zoster was confirmed by isolation of VZV in culture. ... http://www.aegis.org/aidsline/1998/dec/m98c3627.html File Name: m98c3627.html, Size: 10KB, Last Modified: Tuesday, December 29, 1998 at 6:29:23 AM |
| 9. |
Acyclovir-Resistant Genital Herpes Found in Person with Healthy Immune System (100%) Abstract: Acyclovir-Resistant Genital Herpes Found in Person with Healthy Immune System. News from NIAID - December 8, 1993 by National Institute of Allergy and Infectious Diseases, National Institutes of Health Researchers at theNational Institute of Allergy and Infectious Diseases. NIAID. report the first document ... http://www.aegis.org/news/nih/1993/nih93095.html File Name: nih93095.html, Size: 6KB, Last Modified: Wednesday, July 29, 1998 at 4:27:10 AM |
| 10. |
Acyclovir-Resistant Genital Herpes Found in Person with Healthy Immune System (100%) Abstract: Acyclovir-Resistant Genital Herpes Found in Person with Healthy Immune System. News from NIAID - December 8, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of HealthResearchers at the. National Institute of Allergy. and Infectious Diseases (. NIAID. ... http://www.aegis.org/news/niaid/1993/cdc93095.html File Name: cdc93095.html, Size: 7KB, Last Modified: Tuesday, July 21, 1998 at 3:03:55 PM |
| 11. |
AEGiS-12IAC: Acyclovir-resistant herpes zoster in 18 HIV-infected patients: Results of treatment with foscarnet. (100%) Abstract: <p><b>OBJECTIVE:</b> To report the epidemiological and clinical features of acyclovir-resistant herpes zoster and to evaluate the efficacy of foscarnet. DESIGN AND </p> <p><b>METHODS:</b> Retrospective study of all consecutive cases of acyclovir-resistant herpes zoster. Herpes zoster was confirmed by isolation o ... http://www.aegis.org/conferences/iac/1998/32269.html File Name: 32269.html, Size: 7KB, Last Modified: Sunday, June 28, 1998 at 8:12:04 PM |
| 12. |
Acute acyclovir neurotoxicity in a hemodialyzed child. (100%) Abstract: A 5-year-old girl with a kidney transplant developed post-transplant Epstein-Barr virus-induced lymphoproliferative disease. ... http://www.aegis.org/pubs/medline/1998/jan/m9819293.html File Name: m9819293.html, Size: 5KB, Last Modified: Saturday, January 31, 1998 at 10:00:00 PM |
| 13. |
Lack of association between acyclovir use and survival in an observational cohort enrolled by the community program for clinical research on AIDS (CPCRA). (100%) Abstract: Objective: To evaluate the effect of acyclovir use on survival in HIV seropositive persons enrolled in an observational study by 17 units conducting community-based clinical trials in the United States . Design: Analyses were conducted on 2,368 HI ... http://www.aegis.org/aidsline/1996/nov/m96b0441.html File Name: m96b0441.html, Size: 9KB, Last Modified: Thursday, November 28, 1996 at 8:12:04 PM |
| 14. |
Herpes simplex virus resistance to acyclovir: clinical relevance. (100%) Abstract: Herpes simplex virus (HSV) infections are very common in the general population and can be treated with the nucleoside analogue acyclovir. Acyclovir is initially phosphorylated intracellularly in HSV-infected cells by a viral-specific thymidine kinase to acyclovir-monophosphate. ... http://www.aegis.org/aidsline/1996/apr/m9640260.html File Name: m9640260.html, Size: 10KB, Last Modified: Sunday, April 28, 1996 at 8:12:04 PM |
| 15. |
AEGiS-03CROI: Lack of association between acyclovir use and survival in an observational cohort enrolled by the community program for clinical research on AIDS (CPCRA). (100%) Abstract: Use of acyclovir was not associated with improved survival in this large cohort of 2,368 HIV-infected patients, and our findings suggest that intermittent use of acyclovir may be associated with an increased risk of death. Selection biases could have a marked effect on these findings as well as findings from other obse ... http://www.aegis.org/conferences/croi/1996/367.html File Name: 367.html, Size: 8KB, Last Modified: Sunday, January 28, 1996 at 8:12:04 PM |
| 16. |
Acyclovir controversy. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. (100%) Abstract: Two reports submitted at the Second National Conference on Human Retroviruses reignited the controversy surrounding acyclovir s potential effect on survival in HIV-infected persons. One study found no differences in survival between those using acyclovir and those not using the drug, however, it is argued that the stu ... http://www.aegis.org/aidsline/1995/dec/m95c3146.html File Name: m95c3146.html, Size: 9KB, Last Modified: Thursday, December 28, 1995 at 8:12:04 PM |
| 17. |
Comparison of AZT alone with AZT plus acyclovir on P24 antigen status. (100%) Abstract: Objective: To determine if P24 antigenaemia conversion was different in patients receiving AZT versus AZT/ Acyclovir . Methods: Sample consisted of 68 HIV seropositive subjects who were participating in the 3rd ye ... http://www.aegis.org/aidsline/1995/dec/m95c1711.html File Name: m95c1711.html, Size: 9KB, Last Modified: Thursday, December 28, 1995 at 8:12:04 PM |
| 18. |
Does acyclovir prolong survival? (100%) Abstract: For several years there has been confusion over the possibility that the anti-herpes drug acyclovir can prolong the survival of people with AIDS. Three studies published in recent years have suggested that the drug does improve the life expectancy of people with low CD4 counts, but a further two studies reported last m ... http://www.aegis.org/pubs/atu/1995/atu2701.html File Name: atu2701.html, Size: 16KB, Last Modified: Tuesday, February 28, 1995 at 3:00:00 PM |
| 19. |
Acyclovir/zidovudine combination therapy and AIDS survival. Multicenter AIDS Cohort Study. (100%) Abstract: OBJECTIVE: To examine the effect of acyclovir use on disease progression and survival in zidovudine treated HIV + individuals. METHODS: Prospective cohort study of gay and bisexual men seen semiannually. Intent to treat Cox models were fit to determine the relationship between use of acyclovir (modelled as a time depet ... http://www.aegis.org/aidsline/1994/dec/m94c3621.html File Name: m94c3621.html, Size: 10KB, Last Modified: Wednesday, December 28, 1994 at 8:12:04 PM |
| 20. |
Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study. European-Australian Acyclovir Study Group [published erratum appears in AIDS 1994 Jun;8(6):following 859] (100%) Abstract: OBJECTIVE: To determine the efficacy of high-dose oral acyclovir in preventing cytomegalovirus ( CMV ) and other herpesvirus disease in patients with advanced HIV disease and to evaluate its effect on patient survival. DESIGN: ... http://www.aegis.org/aidsline/1994/nov/m94b0367.html File Name: m94b0367.html, Size: 10KB, Last Modified: Monday, November 28, 1994 at 8:12:04 PM |
| 21. |
AEGiS-Glasgow [P59] ORAL VALACICLOVIR - INCREASED ACYCLOVIR BIOAVAILABILITY IN DIFFERENT PATIENT POPULATIONS (100%) Abstract: The delivery of increased plasma acyclovir concentrations following oral valaciclovir is achieved in advanced HIV, BMT, liver disease and ESRD patients. This should enable effective oral treatment and suppression of herpes viruses including CMV in a range of patient populations. ... http://www.aegis.org/conferences/hiv-glasgow/1994/p59.html File Name: p59.html, Size: 7KB, Last Modified: Friday, November 18, 1994 at 8:12:04 PM |
| 22. |
Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). (100%) Abstract: The acyclic nucleoside phosphonate (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) was used topically for the treatment of persistent mucocutaneous infections in two cases. One patient with AIDS suffered from a perineal lesion due to infection with herpes simplex virus type 2 (HSV-2) and did not respond to ... http://www.aegis.org/aidsline/1994/oct/m94a0262.html File Name: m94a0262.html, Size: 10KB, Last Modified: Friday, October 28, 1994 at 8:12:04 PM |
| 23. |
The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study. (100%) Abstract: OBJECTIVE: To examine the effect of acyclovir use on disease progression and survival in human immunodeficiency virus (HIV)-seropositive persons treated with zidovudine. SETTING: Four university-based or -affiliated clinics. DESIGN: Prospective cohort study of homosexual and bis ... http://www.aegis.org/aidsline/1994/sep/m9490226.html File Name: m9490226.html, Size: 12KB, Last Modified: Wednesday, September 28, 1994 at 8:12:04 PM |
| 24. |
AEGiS-10IAC: Acyclovir/zidovudine combination therapy and AIDS survival. Multicenter AIDS Cohort Study. (100%) Abstract: <p><b>OBJECTIVE</b>: To examine the effect of acyclovir use on disease progression and survival in zidovudine treated HIV + individuals.</p> <p><b>METHODS</b>: Prospective cohort study of gay and bisexual men seen semiannually. Intent to treat Cox models were fit to determine the relationship between use of acyclovi ... http://www.aegis.org/conferences/iac/1994/060b.html File Name: 060b.html, Size: 6KB, Last Modified: Thursday, August 04, 1994 at 8:12:04 PM |
| 25. |
Acyclovir diphosphate dimyristoylglycerol: a phospholipid prodrug with activity against acyclovir-resistant herpes simplex virus. (100%) Abstract: Infection with herpes simplex viruses (HSVs) resistant to treatment with acyclovir (9-[(2-hydroxyethoxy)-methyl]guanine, Zovirax ) is a growing clinical problem in patients with AIDS and other immunosuppressed states. Most virus isolates resistant to acyclovir are deficient or de ... http://www.aegis.org/aidsline/1994/mar/m9430294.html File Name: m9430294.html, Size: 12KB, Last Modified: Monday, March 28, 1994 at 8:12:04 PM |
| 26. |
Valaciclovir (BW256U87): the L-valyl ester of acyclovir. (100%) Abstract: Valaciclovir (BW256U87) is an L-valyl ester of acyclovir , which is extensively and almost completely converted to acyclovir. In healthy human volunteers, single valaciclovir doses of 100-1000 mg resulted in dose-proportional increases in acyclovir area under the curve (AUC). The ... http://www.aegis.org/aidsline/1994/mar/m9430852.html File Name: m9430852.html, Size: 10KB, Last Modified: Monday, March 28, 1994 at 8:12:04 PM |
| 27. |
Medical Update: Acyclovir Resurfaces (100%) Abstract: Acyclovir was approved over a decade ago by the FDA as a treatment for herpes. It has proven to be an excellent anti-herpes drug, but its role in fighting HIV has not yet been firmly established. CMV is one of the opportunistic infections for which we have not developed an effective prophylaxis. Since CMV is a cousin t ... http://www.aegis.org/pubs/bala/1994/ba940301.html File Name: ba940301.html, Size: 6KB, Last Modified: Tuesday, March 01, 1994 at 3:00:00 PM |
| 28. |
Antivirals for the treatment of herpesvirus infections. (100%) Abstract: Agents available to treat herpesvirus infections include idoxuridine, trifluridine, vidarabine and acyclovir for the topical treatment of herpetic eye infections; vidarabine and acyclovir for the systemic (intravenous) treatment of herpes encephalitis; acyclovir for the topical ... http://www.aegis.org/aidsline/1994/jan/m9410555.html File Name: m9410555.html, Size: 9KB, Last Modified: Friday, January 28, 1994 at 8:12:04 PM |
| 29. |
Acyclovir-Resistant Genital Herpes Found in Person with Healthy Immune System (100%) Abstract: Acyclovir-Resistant Genital Herpes Found in Person with Healthy Immune System. News from NIAID - December 8, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of HealthResearchers at the National Institute of Allergy and Infectious Diseases (. NIAID. ... http://www.aegis.org/pubs/cdc_fact_sheets/1993/cdc93095.html File Name: cdc93095.html, Size: 7KB, Last Modified: Saturday, January 08, 1994 at 10:00:00 PM |
| 30. |
Double blind, placebo controlled trial of high dose acyclovir for the prevention of cytomegalovirus (CMV) disease in late stage HIV disease. European-Australian Acyclovir Study Group. (100%) Abstract: OBJECTIVES: To evaluate the efficacy and safety of high dose acyclovir as prophylaxis against CMV disease in HIV seropositives with low CD4 positive cell (CD4) counts and to ascertain any survival benefit. METHODS: Three h ... http://www.aegis.org/aidsline/1992/dec/m92c5336.html File Name: m92c5336.html, Size: 10KB, Last Modified: Monday, December 28, 1992 at 8:12:04 PM |
|   |
|
|   |
|